Skip to main content

Table 1 Characteristics of included studies evaluating the efficacy of colchicine in COVID-19

From: The role of colchicine in the management of COVID-19: a Meta-analysis

Authors

Year of publication

Type of study

Study population

Participants (Colchicine/ Control)

Colchicine drug dose

Control

Outcomes

Deftereos et al.

2020

RCT

Hospitalized COVID-19 adult patients

55/50

Loading dose: 1.5 mg followed by 0.5 mg 60 minutes later.

Maintenance dose: 0.5 mg twice daily until hospital discharge or for 21 days.

Standard treatment

Mortality, Mechanical Ventilation

Tardif et al.

2021

RCT

Non-hospitalized COVID-19 adult patients

2235/2253

0·5 mg twice per day for the first 3 days and then once per day for 27 days

Placebo

Mortality, Hospitalization, Mechanical Ventilation

Lopes et al.

2021

RCT

Hospitalized COVID-19 adult patients

36/36

0.5 mg 3 times daily for 5 days, then 0.5 mg twice daily for 5 days

Placebo

Mortality, ICU Admission, ICU length of stay

RECOVERY Collaborative Group

2021

RCT

Hospitalized COVID-19 adult patients

5610/5730

1 mg followed by 500 μg 12 hours later and then 500 μg twice a day for 10 days or until discharge

Standard care

Mortality

Sandhu et al.

2020

NRCT

Hospitalized COVID-19 adult patients

34/78

0.6 mg twice daily for 3 days and then 0.6 mg daily for 12 days

Standard care

Mortality, rate of intubation, rate of hospital discharge

Mareev et al.

2021

NRCT

Hospitalized COVID-19 adult patients

21/22

1 mg colchicine during the first 1–3 days followed by 0.5 mg/day

Placebo

Mortality, length of hospital stay.

Brunetti et al.

2020

Cohort

Hospitalized COVID-19 adult patients

33/33

loading dose: 1.2 mg. maintenance dose: 0.6 mg twice daily

Standard care

Mortality, hospital discharge, clinical improvement

Scarsi et al.

2020

Cohort

Hospitalized COVID-19 adult patients

122/140

colchicine 1 mg/day (reduced to 0.5 mg/day, if severe diarrhoea)

Standard care

survival

  1. RCT Randomized controlled clinical trial, NRCT Nonrandomized controlled clinical trial